Nationwide Fund Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
Nationwide Fund Advisors's DGX Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 76,668 shares — an estimated $7.18M sold.
Nationwide Fund Advisors first reported a position in DGX in Q2 2013 and held it in 18 quarters. The position peaked at $12.3M in Q1 2015. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 76,668 Quest Diagnostics shares in Q4 2017, an estimated $7.18M.
- Nationwide Fund Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's Quest Diagnostics position peaked at $12.3M in Q1 2015.
- 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.